Literature DB >> 12403880

Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study.

N S Godtfredsen1, J Vestbo, M Osler, E Prescott.   

Abstract

BACKGROUND: Little is known about the effects of changes in smoking habits on the subsequent risk of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the relationship between smoking cessation and reduction and admission to hospital for COPD in a general population sample.
METHODS: A total of 19,709 participants from three prospective population studies in Copenhagen were followed with record linkage for date of first hospital admission for COPD until 1998 (mean follow up 14 years). Heavy smokers (>/=15 cigarettes/day) who reduced their tobacco consumption by at least 50% between the two initial examinations without quitting and smokers who stopped smoking during this time were compared with continuous heavy smokers using a Cox proportional hazards model.
RESULTS: During the follow up period 1,260 subjects (741 men and 519 women) were admitted to hospital for COPD. After multivariate adjustment, quitting smoking was associated with a significant reduction in the risk of hospital admission. The relative hazard (HR) was 0.57 (95% confidence interval (CI) 0.33 to 0.99). Those who reduced smoking did not show a significantly lower risk of hospitalisation than continuing heavy smokers (HR 0.93 (95% CI 0.73 to 1.18)). Exclusion of events during the first 5 study years, detailed adjustment for lung function, or restriction of analyses to participants with impaired pulmonary function did not reverse the observed trend.
CONCLUSIONS: Self-reported smoking cessation is associated with a reduction in the risk of COPD morbidity of approximately 40%; the benefit of smoking reduction is questionable.

Entities:  

Mesh:

Year:  2002        PMID: 12403880      PMCID: PMC1746230          DOI: 10.1136/thorax.57.11.967

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

Review 1.  Reduced smoking: an introduction and review of the evidence.

Authors:  J R Hughes
Journal:  Addiction       Date:  2000-01       Impact factor: 6.526

2.  Ability of smokers to reduce their smoking and its association with future smoking cessation.

Authors:  J R Hughes; K M Cummings; A Hyland
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

3.  Clearing the smoke: the science base for tobacco harm reduction--executive summary.

Authors:  K Stratton; P Shetty; R Wallace; S Bondurant
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

4.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Authors:  R D Hurt; G A Croghan; T D Wolter; I T Croghan; K P Offord; G M Williams; M V Djordjevic; J P Richie; A M Jeffrey
Journal:  Nicotine Tob Res       Date:  2000-11       Impact factor: 4.244

7.  Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Authors:  M Pelkonen; H Tukiainen; M Tervahauta; I L Notkola; S L Kivelä; Y Salorinne; A Nissinen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

8.  Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers.

Authors:  N S Godtfredsen; E Prescott; M Osler; J Vestbo
Journal:  Prev Med       Date:  2001-07       Impact factor: 4.018

9.  Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety.

Authors:  C T Bolliger; J P Zellweger; T Danielsson; X van Biljon; A Robidou; A Westin; A P Perruchoud; U Säwe
Journal:  BMJ       Date:  2000-08-05

10.  The costs of treating COPD in the United States.

Authors:  S A Strassels; D H Smith; S D Sullivan; P S Mahajan
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

View more
  53 in total

Review 1.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

2.  How should we define light or intermittent smoking? Does it matter?

Authors:  Corinne G Husten
Journal:  Nicotine Tob Res       Date:  2009-02-20       Impact factor: 4.244

Review 3.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

4.  Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.

Authors:  Stefan Andreas; Thomas Hering; Stephan Mühlig; Dennis Nowak; Tobias Raupach; Heinrich Worth
Journal:  Dtsch Arztebl Int       Date:  2009-04-17       Impact factor: 5.594

Review 5.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

6.  Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs.

Authors:  Jerry A Krishnan; Hélène A Gussin; Valentin Prieto-Centurion; Jamie L Sullivan; Farhan Zaidi; Byron M Thomashow
Journal:  Chronic Obstr Pulm Dis       Date:  2015

7.  Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study.

Authors:  Timothy L Lash; Martin B Johansen; Steffen Christensen; John A Baron; Kenneth J Rothman; Jens G Hansen; Henrik Toft Sørensen
Journal:  Lung       Date:  2010-12-19       Impact factor: 2.584

Review 8.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

9.  Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study.

Authors:  Noora Louhelainen; Harri Stark; Witold Mazur; Paula Rytilä; Ratko Djukanovic; Vuokko L Kinnula
Journal:  BMC Pulm Med       Date:  2010-03-14       Impact factor: 3.317

Review 10.  Strategies for improving outcomes of COPD exacerbations.

Authors:  Tom Wilkinson; J A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.